Zhejiang Jianfeng Group Co., Ltd. (SHA:600668)
7.23
0.00 (0.00%)
Jul 30, 2026, 3:00 PM CST
Zhejiang Jianfeng Group Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,520 | 2,568 | 2,876 | 2,893 | 3,560 | 3,805 |
Revenue Growth | -11.84% | -10.74% | -0.58% | -18.73% | -6.43% | 17.17% |
Gross Profit Gross Profit Growth | 484.42 | 541.64 | 675.68 | 638.13 | 953.69 | 1,231 |
Operating Income Operating Income Growth | -45.16 | 1.5 | 144 | 80.72 | 306.74 | 535.8 |
Net Income Net Income Growth | -188.7 | 411.9 | 107.99 | 93.76 | 287.72 | 924.08 |
Earnings Per Share EPS Growth | -0.45 | 1.00 | 0.26 | 0.23 | 0.70 | 2.24 |
EPS Growth | - | 281.72% | 15.15% | -67.56% | -68.72% | 58.12% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Offset of Business Segment Offset of Business Segment Growth | -23.58 |
Building Materials Building Materials Growth | 1,197 |
Other Industries Other Industries Growth | 248.67 |
Pharmaceutical Industry Pharmaceutical Industry Growth | 851.17 |
Health Products Industry Health Products Industry Growth | 177.25 |
Total Total Growth | 2,451 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 221.94 | 253.32 | 264.29 | 211.28 | 373.16 | 296.68 |
Total Debt Total Debt Growth | 802.16 | 666.83 | 580.44 | 543.85 | 482.28 | 113.37 |
Net Cash (Debt) Net Cash Growth | -580.23 | -413.5 | -316.15 | -332.57 | -109.12 | 183.31 |
Net Cash Growth | - | - | - | - | - | 15.50% |
Net Cash Per Share Net Cash Per Share Growth | -1.37 | -1.00 | -0.77 | -0.81 | -0.27 | 0.44 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 247.88 | 223.71 | 412.11 | 42.43 | 383.33 | 475.35 |
Capital Expenditures CapEx Growth | -734.11 | -674.99 | -338.83 | -237.46 | -456.36 | -304.15 |
Free Cash Flow Free Cash Flow Growth | -486.22 | -451.28 | 73.27 | -195.03 | -73.03 | 171.2 |
Free Cash Flow Growth | - | - | - | - | - | 209.59% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 19.22% | 21.09% | 23.49% | 22.05% | 26.79% | 32.36% |
Operating Margin | -1.79% | 0.06% | 5.01% | 2.79% | 8.62% | 14.08% |
Pretax Margin | -6.81% | 17.45% | 6.99% | 4.57% | 12.30% | 32.18% |
Profit Margin | -7.49% | 16.04% | 3.75% | 3.24% | 8.08% | 24.29% |
FCF Margin | -19.29% | -17.58% | 2.55% | -6.74% | -2.05% | 4.50% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.100 | 0.100 | 0.083 | 0.083 | 0.125 | 0.417 |
Dividend Per Share Growth | 0% | 20.05% | 0% | -33.36% | -70.00% | 25.02% |
Dividend Yield | 1.41% | 0.90% | 1.00% | 0.94% | 1.23% | 2.96% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 11.33 | 32.34 | 40.55 | 15.24 | 6.81 |
P/FCF Ratio | - | - | 47.66 | - | - | 36.74 |
PS Ratio | 1.18 | 1.82 | 1.21 | 1.31 | 1.23 | 1.65 |